Development of Chemical Entities Endowed with Potent Fast-Killing Properties against


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
24 10 2019
Historique:
pubmed: 1 10 2019
medline: 17 6 2020
entrez: 1 10 2019
Statut: ppublish

Résumé

One of the attractive properties of artemisinins is their extremely fast-killing capability, quickly relieving malaria symptoms. Nevertheless, the unique benefits of these medicines are now compromised by the prolonged parasite clearance times and the increasing frequency of treatment failures, attributed to the increased tolerance of

Identifiants

pubmed: 31566384
doi: 10.1021/acs.jmedchem.9b01099
pmc: PMC6816013
doi:

Substances chimiques

Antimalarials 0
Artemisinins 0
ERG1 Potassium Channel 0
KCNH2 protein, human 0
Protozoan Proteins 0
Thiazoles 0
artemisinin 9RMU91N5K2
Cyclic GMP-Dependent Protein Kinases EC 2.7.11.12

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9217-9235

Subventions

Organisme : Medical Research Council
ID : G1000779
Pays : United Kingdom

Références

Biochim Biophys Acta. 2010 Mar;1804(3):604-12
pubmed: 19840874
Anal Chem. 2012 Aug 21;84(16):7188-94
pubmed: 22881393
Lancet Infect Dis. 2016 Mar;16(3):357-65
pubmed: 26774243
BMC Genomics. 2009 Jun 17;10:270
pubmed: 19534804
Nat Rev Microbiol. 2010 Apr;8(4):272-80
pubmed: 20208550
Nat Commun. 2011 Nov 29;2:565
pubmed: 22127061
PLoS Pathog. 2008 Nov;4(11):e1000201
pubmed: 18989463
MBio. 2019 Feb 19;10(1):
pubmed: 30782661
PLoS One. 2012;7(2):e30949
pubmed: 22383983
Bioinformatics. 2010 Jan 15;26(2):198-204
pubmed: 19942586
Curr Drug Targets. 2014 May;15(5):539-50
pubmed: 24568585
J Proteome Res. 2018 Apr 6;17(4):1730-1740
pubmed: 29565595
Eukaryot Cell. 2010 Jan;9(1):37-45
pubmed: 19915077
Bioorg Med Chem Lett. 2019 Feb 1;29(3):509-514
pubmed: 30553738
J Cell Biochem. 2011 May;112(5):1295-310
pubmed: 21312235
Future Med Chem. 2012 Dec;4(18):2295-310
pubmed: 23234552
Pharmazie. 2008 Mar;63(3):194-9
pubmed: 18444507
Nat Commun. 2017 Nov 1;8(1):1232
pubmed: 29089541
PLoS Biol. 2008 Jun 3;6(6):e139
pubmed: 18532880
Biochem J. 2003 Sep 1;374(Pt 2):559-65
pubmed: 12817987
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1298-1303
pubmed: 29358379
Science. 2019 Aug 30;365(6456):
pubmed: 31467193
Nat Chem Biol. 2012 Apr 29;8(6):576-82
pubmed: 22544264
Nat Commun. 2019 Mar 11;10(1):1155
pubmed: 30858367
BMC Genomics. 2004 Oct 12;5:79
pubmed: 15479470
Mol Microbiol. 2016 Oct;102(2):349-363
pubmed: 27425827
Antimicrob Agents Chemother. 2014 Dec;58(12):7292-302
pubmed: 25267664
Nat Commun. 2015 Jul 07;6:7285
pubmed: 26149123
Nat Biotechnol. 2011 Mar;29(3):255-65
pubmed: 21258344
Science. 2015 Jan 23;347(6220):428-31
pubmed: 25502314
Proteins. 2005 Jan 1;58(1):180-9
pubmed: 15515182
BMC Med. 2015 Mar 31;13:67
pubmed: 25889405
PLoS One. 2014 Sep 04;9(9):e105732
pubmed: 25188378
Nat Commun. 2015 Mar 31;6:6715
pubmed: 25823686
Trends Parasitol. 2018 Oct;34(10):843-860
pubmed: 30122551
Nat Commun. 2017 Sep 5;8(1):430
pubmed: 28874661
Antimicrob Agents Chemother. 2015;59(6):3298-305
pubmed: 25801574
Bioorg Med Chem Lett. 2018 Oct 15;28(19):3168-3173
pubmed: 30174152
N Engl J Med. 2014 Jul 31;371(5):411-23
pubmed: 25075834
Cell Microbiol. 2011 Jun;13(6):836-45
pubmed: 21371233
Nat Biotechnol. 2007 Sep;25(9):1035-44
pubmed: 17721511
Bioorg Med Chem Lett. 2007 Jul 1;17(13):3558-61
pubmed: 17475489
Mol Syst Biol. 2014 Oct 30;10:757
pubmed: 25358341
PLoS Pathog. 2009 Sep;5(9):e1000599
pubmed: 19779564
Clin Infect Dis. 2009 Dec 1;49(11):1638-40
pubmed: 19877970
N Engl J Med. 2011 Sep 22;365(12):1073-5
pubmed: 21992120
Cochrane Database Syst Rev. 2013 Oct 25;(10):CD008492
pubmed: 24163021
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2607-18
pubmed: 22889911
Anal Chem. 2014 Apr 1;86(7):3594-601
pubmed: 24579773
PLoS Med. 2006 Dec;3(12):e528
pubmed: 17194200
Sci Rep. 2017 May 30;7:46126
pubmed: 28555643
PLoS Biol. 2014 Mar 04;12(3):e1001806
pubmed: 24594931
Bioorg Med Chem Lett. 2006 May 15;16(10):2817-21
pubmed: 16517161
Nat Chem Biol. 2008 Jun;4(6):347-56
pubmed: 18454143
Mol Biochem Parasitol. 2006 Mar;146(1):78-88
pubmed: 16325279

Auteurs

Alexios N Matralis (AN)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.
Biomedical Sciences Research Center "Alexander Fleming" , Fleming 34 Street , 16672 Vari , Greece.

Adnan Malik (A)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Maria Penzo (M)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.
Faculty of Infectious and Tropical Diseases , London School of Hygiene & Tropical Medicine , London WC1E 7HT , U.K.

Inmaculada Moreno (I)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Maria J Almela (MJ)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Isabel Camino (I)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Benigno Crespo (B)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Anas Saadeddin (A)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Sonja Ghidelli-Disse (S)

Cellzome GmbH, a GlaxoSmithKline Company , Meyerhofstrasse 1 , 69117 Heidelberg , Germany.

Lourdes Rueda (L)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Felix Calderon (F)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Simon A Osborne (SA)

LifeArc, Accelerator Building, Open Innovation Campus , Stevenage SG1 2FX , U.K.

Gerard Drewes (G)

Cellzome GmbH, a GlaxoSmithKline Company , Meyerhofstrasse 1 , 69117 Heidelberg , Germany.

Markus Böesche (M)

Cellzome GmbH, a GlaxoSmithKline Company , Meyerhofstrasse 1 , 69117 Heidelberg , Germany.

Elena Fernández-Álvaro (E)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

Jose Ignacio Martin Hernando (JI)

Tres Cantos, Medicines Development Campus, DDW, GlaxoSmithKline , Severo Ochoa 2 , 28760 Tres Cantos , Madrid , Spain.

David A Baker (DA)

Faculty of Infectious and Tropical Diseases , London School of Hygiene & Tropical Medicine , London WC1E 7HT , U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH